- Home
- PTCT vs INSP Comparison
PTCT vs INSP Comparison
Compare PTCT & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTCT
- INSP
- Stock Information
- Founded
- PTCT 1998
- INSP 2007
- Country
- PTCT United States
- INSP United States
- Employees
- PTCT N/A
- INSP N/A
- Industry
- PTCT Biotechnology: Pharmaceutical Preparations
- INSP Medical/Dental Instruments
- Sector
- PTCT Health Care
- INSP Health Care
- Exchange
- PTCT Nasdaq
- INSP Nasdaq
- Market Cap
- PTCT 5.3B
- INSP 3.8B
- IPO Year
- PTCT 2013
- INSP 2018
- Fundamental
- Price
- PTCT $74.90
- INSP $83.19
- Analyst Decision
- PTCT Buy
- INSP Buy
- Analyst Count
- PTCT 17
- INSP 16
- Target Price
- PTCT $73.24
- INSP $139.40
- AVG Volume (30 Days)
- PTCT 1.1M
- INSP 1.2M
- Earning Date
- PTCT 11-04-2025
- INSP 11-03-2025
- Dividend Yield
- PTCT N/A
- INSP N/A
- EPS Growth
- PTCT N/A
- INSP 34.77
- EPS
- PTCT 8.94
- INSP 1.48
- Revenue
- PTCT $1,779,150,000.00
- INSP $882,622,000.00
- Revenue This Year
- PTCT $119.02
- INSP $14.83
- Revenue Next Year
- PTCT N/A
- INSP $14.44
- P/E Ratio
- PTCT $8.45
- INSP $57.49
- Revenue Growth
- PTCT 97.54
- INSP 16.81
- 52 Week Low
- PTCT $35.95
- INSP $70.77
- 52 Week High
- PTCT $77.40
- INSP $216.01
- Technical
- Relative Strength Index (RSI)
- PTCT 76.53
- INSP 52.03
- Support Level
- PTCT $69.23
- INSP $79.61
- Resistance Level
- PTCT $77.43
- INSP $92.01
- Average True Range (ATR)
- PTCT 2.74
- INSP 3.96
- MACD
- PTCT 0.26
- INSP 0.49
- Stochastic Oscillator
- PTCT 80.14
- INSP 58.85
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.